Risk is all around us, an inherent part of life. And in the world of development, there are also risks, including war, civil disturbance and expropriation. Junaid Kamal Ahmad: When Egypt did in fact ...
Join us on 27 March 2026 for a webinar on the role of test centres in dramatically de-risking geothermal development, and how ...
Right now leaders from both the private and public sectors are gathering at COP29 in Baku, Azerbaijan—where one of the leading topics is how to finance the pursuit of net-zero. Reaching that goal will ...
The liver is accountable for metabolizing most medications and is therefore one of the primary tissues affected by adverse drug reactions. Most classes of medicine can cause drug-induced liver injury ...
Can you tell us about the selection strategy you used to evaluate syringe systems to deliver your drug product? As combination products have become more complex and sensitive, especially with more ...
Viral vectors are critical vehicles for the delivery of life-saving cell and gene therapies. Adeno-associated virus (AAV) and lentiviral vectors (LVV), two of the most widely used vector platforms, ...
Pilot-plant success is one of the biggest de-risking moments in resources investing, proving the process works at scale For companies like Elevate Uranium, Pursuit Minerals and Green Critical Minerals ...
The Department of Energy (DOE) and state-owned Land Bank of the Philippines on Tuesday signed an accord to operationalize a multi-million dollar loan program to attract investors in geothermal energy ...
China’s industrial overcapacity is reshaping trade and supply chain dynamics across ASEAN. As China’s largest export destination, ASEAN is absorbing a surge of Chinese exports—up 12% in 2024—while its ...
Antibody-drug conjugates (ADCs) represent the most successful class of active targeting drug-delivery systems, however, despite the increasing number of FDA approvals treatment-related adverse events ...
ACR246, a first in next-generation 5T4-ADC, as a potential choice of treating 5T4-positive solid tumors. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results